Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)
Public ClinicalTrials.gov record NCT00163514. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Trial Designed to Assess the Efficacy and Safety of Ciclesonide Applied as a Nasal Spray at Three Dose Levels (200 Mcg, 100 Mcg, or 25 Mcg, Once Daily) in the Treatment of Perennial Allergic Rhinitis (PAR) in Patients 6-11 Years of Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate the safety and effectiveness of ciclesonide nasal spray as compared with placebo (inactive substance) nasal spray in relieving symptoms of perennial allergic rhinitis.
Study identification
- NCT ID
- NCT00163514
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 636 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 6 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2004
- Primary completion
- Jun 30, 2005
- Completion
- Jun 30, 2005
- Last update posted
- Dec 1, 2016
2004 – 2005
United States locations
- U.S. sites
- 58
- U.S. states
- 26
- U.S. cities
- 55
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Altana Pharma/Nycomed | Oxford | Alabama | 36203 | — |
| Altana Pharma/Nycomed | Huntington Beach | California | 92647 | — |
| Altana Pharma/Nycomed | Mission Viejo | California | 92691 | — |
| Altana Pharma/Nycomed | Newport Beach | California | CA 92660 | — |
| Altana Pharma/Nycomed | Orange | California | 92868 | — |
| Altana Pharma/Nycomed | Palmdale | California | 93551 | — |
| Altana Pharma/Nycomed | San Diego | California | 92120 | — |
| Altana Pharma/Nycomed | San Diego | California | 92123 | — |
| Altana Pharma/Nycomed | San Jose | California | 95117 | — |
| Altana Pharma/Nycomed | Stockton | California | 95207 | — |
| Altana Pharma/Nycomed | Walnut Creek, CA | California | 94598 | — |
| Altana Pharma/Nycomed | Coral Gables | Florida | 33134 | — |
| Altana Pharma/Nycomed | Ocala | Florida | 34471 | — |
| Altana Pharma/Nycomed | Atlanta | Georgia | 30342 | — |
| Altana Pharma/Nycomed | Gainesville | Georgia | 30501 | — |
| Altana Pharma/Nycomed | Savannah | Georgia | 31406 | — |
| Altana Pharma/Nycomed | Normal | Illinois | 61761 | — |
| Altana Pharma/Nycomed | Indianapolis | Indiana | 46208 | — |
| Altana Pharma/Nycomed | Dubuque | Iowa | 52001 | — |
| Altana Pharma/Nycomed | Overland Park | Kansas | 66210 | — |
| Altana Pharma/Nycomed | Metairie | Louisiana | 70001 | — |
| Altana Pharma/Nycomed | Shreveport | Louisiana | 71130 | — |
| Altana Pharma/Nycomed | Rockville | Maryland | 20850 | — |
| Altana Pharma/Nycomed | Wheaton | Maryland | 20902 | — |
| Altana Pharma/Nycomed | North Dartmouth | Massachusetts | 02747 | — |
| Altana Pharma/Nycomed | Minneapolis | Minnesota | 55402 | — |
| Altana Pharma/Nycomed | Jefferson City | Missouri | 65101 | — |
| Altana Pharma/Nycomed | Rolla, Mo | Missouri | 65401 | — |
| Altana Pharma/Nycomed | St Louis | Missouri | 63141 | — |
| Altana Pharma/Nycomed | Papillion | Nebraska | 68046 | — |
| Altana Pharma/Nycomed | Brick | New Jersey | 08724 | — |
| Altana Pharma/Nycomed | Skillman | New Jersey | 08558 | — |
| Altana Pharma/Nycomed | Liverpool | New York | 13088 | — |
| Altana Pharma/Nycomed | Raleigh | North Carolina | 27607 | — |
| Altana Pharma/Nycomed | Canton | Ohio | 44718 | — |
| Altana Pharma/Nycomed | Cincinnati, OH | Ohio | 45231 | — |
| Altana Pharma/Nycomed | Sylvania | Ohio | 43560 | — |
| Altana Pharma/Nycomed | Medford | Oregon | 97504 | — |
| Altana Pharma/Nycomed | Portland | Oregon | 97213 | — |
| Altana Pharma/Nycomed | Easton | Pennsylvania | 18045 | — |
| Altana Pharma/Nycomed | Hershey | Pennsylvania | 17033 | — |
| Altana Pharma/Nycomed | Upland | Pennsylvania | 19013 | — |
| Altana Pharma/Nycomed | Charleston | South Carolina | 29407 | — |
| Altana Pharma/Nycomed | Charleston | South Carolina | 29414 | — |
| Altana Pharma/Nycomed | Moncks Corner | South Carolina | 29461 | — |
| Altana Pharma/Nycomed | Spartanburg | South Carolina | 29307 | — |
| Altana Pharma/Nycomed | Austin | Texas | 78750 | — |
| Altana Pharma/Nycomed | El Paso | Texas | 79925 | — |
| Altana Pharma/Nycomed | Fort Worth | Texas | 76132 | — |
| Altana Pharma/Nycomed | Friendswood | Texas | 77546 | — |
| Altana Pharma/Nycomed | Houston | Texas | 77054 | — |
| Altana Pharma/Nycomed | Katy | Texas | 77450 | — |
| Altana Pharma/Nycomed | Salt Lake City | Utah | 84037 | — |
| Altana Pharma/Nycomed | South Burlington | Vermont | 05403 | — |
| Altana Pharma/Nycomed | Burke | Virginia | 22015 | — |
| Altana Pharma/Nycomed | Richmond | Virginia | 23219 | — |
| Altana Pharma/Nycomed | Richmond | Virginia | 23226 | — |
| Altana Pharma/Nycomed | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00163514, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2016 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00163514 live on ClinicalTrials.gov.